| Prev Close | 1.79 |
| Day Low/High | 1.67 / 1.80 |
| 52 Wk Low/High | 0.67 / 6.96 |
| Avg Volume | 3.73M |
| Exchange | NASDAQ |
| Shares Outstanding | 133.05M |
| Market Cap | 238.16M |
| EPS | -1.10 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Investors in MannKind Corp saw new options become available this week, for the April 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new April 20th contracts and identified one put and one call contract of particular interest.
Conference Call to Begin Today at 5:00 PM ET
Investors in MannKind Corp saw new options begin trading today, for the April 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new April 6th contracts and identified the following call contract of particular interest.
Investors in MannKind Corp saw new options begin trading today, for the March 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new March 29th contracts and identified the following put contract of particular interest.
Investors in MannKind Corp saw new options begin trading today, for the March 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new March 23rd contracts and identified one put and one call contract of particular interest.
Investors in MannKind Corp saw new options become available this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new March 16th contracts and identified one put and one call contract of particular interest.
Investors in MannKind Corp saw new options begin trading today, for the March 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new March 2nd contracts and identified the following put contract of particular interest.
Conference Call to Begin Today at 5:00 PM ET
Will the benign backdrop continue next week? Cramer has a defensive game plan, in case earnings chill the market.
Powerhouse performances from Caterpillar and 3M inspire a Dow rally, leading the index to new all-time highs in its 54th record close of the year.
Better-than-expected earnings from a number of key Dow components sweep markets higher.
Afrezza® is the only inhaled rapid-acting mealtime insulin approved by the U.S. Food & Drug Administration. The innovative delivery system reduces injections while improving glycemic control in adult patients with diabetes
Scheduled for Monday, October 2, 2017 at 9 AM ET
Donation of inhalable insulin provides support for those living with diabetes.
Move Places MannKind in Area Rich with Biopharmaceutical Talent
